TIGM Shares Genetic Resource Data to Promote Medical Research Throughout the World
News Aug 08, 2007
Texas Institute for Genomic Medicine (TIGM) has responded to the National Institutes of Health's call for mouse genetic sequence data to be shared with the scientific research community worldwide. As a result, TIGM recently submitted 276,372 nucleotide sequence tags generated from its world's largest gene trap library of C57BL/6 mouse embryonic stem cells, to the Genome Survey Sequences division of the GenBank® database.
The sequence data submission will provide scientists with valuable information in their research efforts to understand and treat the underlying genetic causes of chronic human diseases and conditions.
The GenBank database is accessible by researchers through the Internet and contains gene sequences representing 100,000 distinct organisms to help support pioneering scientific and medical research. TIGM's contribution represents one of the largest single submissions to the GenBank database since its formation in 1982.
The sequence data provided by TIGM will also be distributed by the National Center for Biotechnology Information, a division of NIH, to the European Molecular Biology Laboratory Nucleotide Sequence Database and the DNA Data Bank of Japan.
"We are pleased to support the research community worldwide by contributing the sequence data generated from our gene trap library to GenBank," said Dr. Richard H. Finnell, President of the Texas Institute for Genomic Medicine.
"GenBank is an example of cooperation among the scientific community that taps into the power of genomic information and advances research development globally. We look forward to future opportunities to share our data through the NIH database as well as other databases worldwide," Dr. Finnell added.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.